title: Intensive sequential chemotherapy for children with acute myelogenous leukemia.
authors.affiliation: Division of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston.
authors.forename: H E
authors.initials: HE
authors.lastname: Grier
authors.forename: R D
authors.initials: RD
authors.lastname: Gelber
authors.forename: L A
authors.initials: LA
authors.lastname: Clavell
authors.forename: B M
authors.initials: BM
authors.lastname: Camitta
authors.forename: M P
authors.initials: MP
authors.lastname: Link
authors.forename: M J
authors.initials: MJ
authors.lastname: Garcea
authors.forename: H J
authors.initials: HJ
authors.lastname: Weinstein
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D015337:Multicenter Studies as Topic; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D003630:Daunorubicin